DIMENSIONAL FUND ADVISORS LP

Position in ORMP — Oramed Pharmaceuticals Inc.

CIK 354204 AUSTIN, TX

Position in ORMP

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$974,547

+$436,638 QoQ

Shares Held

202,609

+28.1% QoQ

Ownership

0.487%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#13

of 84 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 81% Shared 19% None 0%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. ORMP ranks #159 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd.	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$974,547	202,609	+28.1%	Shares	Sole	2026-08-11
2026-03-31	$537,909	158,209	+5.1%	Shares	Sole	2026-05-07
2025-12-31	$428,840	150,471	+2.0%	Shares	Sole	2026-02-12
2025-09-30	$389,365	147,487	-11.6%	Shares	Sole	2025-11-12
2025-06-30	$375,521	166,899	+18.3%	Shares	Sole	2025-08-12
2025-03-31	$301,912	141,081	+18.6%	Shares	Sole	2025-05-13
2024-12-31	$287,967	118,995	+143.8%	Shares	Sole	2025-02-13
2024-09-30	$119,083	48,805	+55.1%	Shares	Sole	2024-11-07
2024-06-30	$80,877	31,470	+52.1%	Shares	Sole	2024-08-09
2024-03-31	$60,432	20,696	-24.1%	Shares	Sole	2024-05-10
2023-09-30	$71,213	27,285	—	Shares	Sole	2023-11-09
No filing history on record for this holder in this stock.